Ayamtim
- Wɔatwerɛ nsɛm wei ɛwɔ Asante kasa mu
Ayamtim ne sɛ nnipa ayamdeɛ yɛ den na ntumi mpui mma abɔten.[1] Mpempii no yaane no den asan aho. [2] Nsɛnkyerɛnne foforɔ bi nso ne yam yadeɛ, yam bobom, ɛyɛ wosɛ wonyaa wo nan nwieɛ.[3] Nnoɔma a ɛha agye wɔ ayamtuo ho ne hemorrhoids, anal fissure or fecal impaction.[4] Mpɛn dodoɔ a ɛwɔ sɛ mpanimfoɔ gya wɔn nan yɛ mprɛnsa dabiara ɛna mprɛnsa nnwɔtwe biara. Nkwadaa ketewa deɛ yɛ mprɛnsa anaa mprɛ nan dabiara ɛna mmɔtofowa nso mprɛnu de rekɔ mprɛnsa dabiara.[5] Nnoɔma a ɛde ayamtim ba dɔɔso. [6]Nea ɛyɛ na ne agyanan a ɛntumi mma ntɛntɛm, irritable bowel syndrome ne pelvic for disorder. [6]Yareɛ a ɛne no sɛ nehypothyroidism, diabetes, Parkinson's disease, celiac disease, non-celiac gluten sensitivity, colon cancer, diverticulitis, and inflammatory bowel disease. [6][7]Nnuro a yɛde ma obi a wanya yamtuo neopioids, certain antacids, calcium channel blockers, and anticholinergics. [6]Opioids boa ma obi a ne yam tuo yam tim.[8] Nnipa ani ba ayamtim ho sɛ obi ahoɔden sɛ te a, anaa ɔnyaa anaemia, mmogya ba n'agyanan mu a, yɛwɔ abakɔsɛm a ɛfa kokoram anaa ayamtuo yi ho a ɛwɔ abusua mu anaasɛ ɛwɔ obi a wanyini so. [9]Kwan a wɔfa so sa saa yareɛ no gyina kwan a ɛfaa so baeɛ na nna dodoɔ a adi. [6]Kwan a ɛbɛtumi aboa ne sɛ wonom nsuo pii, di nnuaba a nsuo wɔm, wodi ɛwoɔ[10] na watenetene w'apom kakra. [6]Sɛ anyɛ adwuma a, wɔbɛtumi de laxatives of the bulk forming agent, osmotic agent, stool softener, or lubricant type ama wo. [6]Wɔde stimulant laxatives no ma wo sɛ ebia nnuro a wɔde maa wo no antumi ansa yareɛ noa.[6] Nea yɛtumi de sa ayamtuo nso ne biofeedback anaasɛ yɛde sekan paepae obi mua. [6]Ɔhamu nkyekyɛmu mmienu dekɔ aduasa na ɛtaa nya ayamtim. [11]Mpanimfoɔ a nso deɛ firi ɔhamu nkyekyɛmu aduonum kɔpem aduoson. [8]Nnipa ɔwɔ United States bɛka bɛyɛ US$250 de tɔ aduro sa ayamtuo bɛyɛ afe.[12]
Nkyerɛaseɛ
[sesa]Ayamtim yɛ nsɛnkyerɛnneɛ na ɛnyɛ yareɛ. Mpempii no, ayamtim yɛ adeɛ a yɛka sɛ yɛn ayamdeɛ ntumi mpui bɛyɛ mprɛnsa nnwɔtwe nnawɔtwe biara.[13] [14]Saa ara nso na, nnipa bɔsoɔ ka nnoɔma a ɛdidisoɔ yi.[15]
- Ayamdeɛ a ɛkyɛ ansa na aba
- Wɔhia mmerɛ pii ansa na ayamdeɛ no aba
- Ayamdeɛ no yɛ den
- Ɛnam sɛ ayamdeɛ no kyɛ ansa na apii no nti ɛma no te yaw.
- Yam yadeɛ
- Mframa gyina ne yam
- the sensation of incomplete bowel evacuation.
Rome III Criteria yɛ nsɛnkyerɛnneɛ ahodoɔ bi a ɛboa ma wɔyɛ nhwehwɛmu no nya gyinapen a ɛfa ayamtim ho a ɛgyina mfeɛ ahodoɔ so. Saa ɔkwan yi boa ma aduyɛfoɔ kyerɛ ayamtim mu yie wɔ gyinapɛn kwan so.
Nnoɔma a ɛde ba
[sesa]Nnoɔma a ɛde ayamtim ba no bɛtumi akyekyɛ ayɛ congenital,ordinary ne Secondary. Deɛ ɛyɛ na paa yɛ ordinary na ɛnha adwene. [16]Ɛbɛtumi agyina mfeɛ a obi adi te sɛ mmɔfra ne mpanimfoɔ so akyekyɛmu.
Primary anaa functional ayamtim kyerɛ nsɛnkyerɛnne bi a ɛkɔso wɔ nnipadua mu a ɛboro bosome nsia a ɛnyi a asɛm biara so te sɛ aduro a obi anom ho nsunsuansoɔ anaa tebea a obi wɔ yareɛ mu. [17]Ɛmfa yam yadeɛ ho, ɛne sɛ ɛda nso firi irritable bowel syndrome ho. Ɛyɛ ayamtim a ɛyɛ na paa na ɛdɔɔso. [18]Wɔ mpanimfoɔ mu no, nnoɔma a ɛde Primary ayamtim ba na ɛdidisoɔ yi: nnuane a yɛ di bi te sɛ nnuane a nsuo nnim, anaa suban bi a yɛda no adi te sɛ yɛn tenetene yɛn mpom. Wɔ mpanimfoɔ paa mu no, nnoɔma a ɛde ba no gyina nnuane a nsuo nnim a wɔdi, wɔnnom nsuo pii, wɔntenetene wɔn mpom, nsunsuansoɔ a wɔnya firi nnuro a wafa mu, hypothyroidism ne colorectal kokoram. Adanseɛ a wɔde bɛsɔ saa nnoɔma yi asene yɛ adeɛ ebi nni hɔ. Ńoɔma a ɛde Secondary no ba yɛ nsunsuansoɔ a ɛwɔ nnuro a wɔnom mu bi te sɛ opiates, endocrine ne metabolic disorders te sɛ hypothyroidism, ne obstruction a ɛfiri colorectal cancer anaa ovarian cancer. [19]Celiac yareɛ ne non-celiac gluten sensitivity nso bɛtumi ama ayamtim aba.[20] Cystocele nso bɛtumi ama ayamtim ɛyɛ koankorɔ aba.[21]
Nnuane
Nnuane a nsuo nnoma a yɛdi, nsuo a yɛnnom bɛtumi de ayamtim aba.[22] Nnuane a nsuo wɔm tumi yi colonic transport time, ɛma ayamdeɛ dɔɔso na mmom ɛma no yɛ mmerɛ nso. Ne saa, nnuane a nsuo nnɔɔso wɔ mu no bɛtumi ama woanya ayamtim a yɛfrɛ no Primary.[23]
Nnuro
Nnuro pii nsunsuansoɔ yɛ ayamtim. Ɛbi ne ( na ɛnyɛ wei nika) opioids, diuretics, antidepressants, antihistamines, antispasmodics, anticonvulsants, tricyclic antidepressants, antiarrythmics, beta-adrenoceptor antagonists, anti-diarrheals, 5-HT3 receptor antagonists bi te sɛ ondansetron, ne aluminum antacids.[24] Calcium channel blockers bi te sɛ nifedipine ne verapamil bɛtumi ama woanya ayamtim. [25]Nnuane nnuro bi te sɛ calcium ne iron nso bɛtumi ama woanya ayamtim ho nsunsuansoɔ.
Tebea a obi kɔ mu sɛ ɔnom aduro bi a
Metabolic ne endocrine haw a ɛbɛtumi de ayamtim aba ne: pheochromocytoma, hypercalcemia, hypothyroidism, hyperparathyroidism, porphyria, chronic kidney disease, pan-hypopituitarism, diabetes mellitus, and cystic fibrosis.[26] Ayamtim nso tumi ba nnipa a wɔwɔ muscular ne myotonic dystrophy. [27]Yareɛ a ɛdidisoɔ a ɛde ayamtim ba ne celiac disease and systemic sclerosis.[28] Ayamtim wɔ kwan ahodoɔ ( mechanical, morphological, anatomical) a ɛfa so ba a ɛne, wɔ ma kwan bɛda colon no a ɛsi ayamdeɛ kwan ma no ba bi te sɛ colorectal cancer, strictures, rectocoles, anal sphincter damage or malformation and post-surgical changes. Nsorom nnoɔma bi a abɛka ho te sɛ malignancies bɛtumi de ayamtim aba.[29] Nea ɛde Ayamtim ba no bi yɛ Neurological, ebi ne anismus, descending perineum syndrome, and Hirschsprung's yareɛ. Hirschsprung yareɛ yɛ adeɛ a ɛyɛ na wɔ mmɔfra mu paa a ɛde ayamtim ba. Anismus ba nnipa kakra bi a wɔwɔ ayamtim a ɛyɛ koankorɔ anaa ayamdeɛ a ɛyɛ den sɛ ɛbɛpui.[30] Akyi nkasɛɛ ne Neurological a ɛntotɔ N'akwan yie bi te sɛ Parkinson's yareɛ ne pelvic floor dysfunction bɛtumi de ayamtim aba. Chagas yareɛ bɛtumi de ayamtim sɛ myenteric plexus sɛe a.[31]
Sɛ wohyɛ da ma yamdeɛ no ka wo mu kyɛ a ɛde ayamtim ba. [34]Nea ɛbɛma obi ayɛ saa no sɛ na onikorɔ no suro yaw a ɛbɛba no, akwadworɔ anaa ɔsuro baabi a nnipadɔm siesie wɔn ho.[34] Sɛ abɔfra ma ne yamdeɛ ka ne mu a nkuranhyɛ, nsuo ne afaseduro a aka abom bɛtumi asi saa ɔhaw no ano kwan.[33] Sɛ wodi wo ho so na wakura mu no nso bɛtumi de anka fissures aba.[35]
Congenital
Nyarewa pii a ɛba wɔ awoɔ mu no nso tumi de ayamtim ba mmɔfra so. Ɛyɛ ekuo bi a ɛda nso firi Hirschsprung (HD) yareɛ a ɛyɛ na ho.[36] Yɛwɔ congenital structural anomalies a ɛde ayamtim ba a ebi ne anterior displacement of the anus, imperforate anus, strictures, and small left colon syndrome.[37]
Beaeɛ a menyaa mmoa firiiɛ
[sesa]- ↑ https://doi.org/10.1016%2Fj.bpg.2009.05.001
- ↑ https://web.archive.org/web/20170315085221/https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/all-content
- ↑ Bharucha, A. E.; Dorn, S. D.; Lembo, A.; Pressman, A. (January 2013). "American Gastroenterological Association medical position statement on constipation". Best Practice & Research: Clinical Gastroenterology (Review). Baillière Tindall. 144 (1): 211–217. doi:10.1053/j.gastro.2012.10.029. PMID 23261064. Archived from the original on 20 February 2022.
- ↑ https://web.archive.org/web/20170315085221/https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/all-content
- ↑ Colombo, Jennifer M.; Wassom, Matthew C.; Rosen, John M. (1 September 2015). "Constipation and Encopresis in Childhood". Pediatrics in Review. 36 (9): 392–401, quiz 402. doi:10.1542/pir.36-9-392. ISSN 1526-3347. PMID 26330473. S2CID 35482415.
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 https://web.archive.org/web/20170315085221/https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/all-content
- ↑ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531555
- ↑ 8.0 8.1 Canadian Agency for Drugs and Technologies in Health (26 June 2014). "Dioctyl Sulfosuccinate or Docusate (Calcium or Sodium) for the Prevention or Management of Constipation: A Review of the Clinical Effectiveness". PMID 25520993.
- ↑ Brenner, DM; Shah, M (June 2016). "Chronic Constipation". Gastroenterology Clinics of North America. 45 (2): 205–16. doi:10.1016/j.gtc.2016.02.013. PMID
- ↑ Li, Yuyuan; Long, Shangqin; Liu, Qiaochu; Ma, Hong; Li, Jianxin; Xiaoking, Wei; Yuan, Jieli; Li, Ming; Hou, Minmin (8 August 2020). "Gut microbiota is involved in the alleviation of loperamide‐induced constipation by honey supplementation in mice". Food Science & Nutrition. NIH. 8 (8): 4388–4398. doi:10.1002/fsn3.1736. PMC 7455974. PMID 32884719.
The results of this study suggested that honey can improve the symptoms of constipation by elevating fecal water content and intestinal transit rate in loperamide‐induced constipation
- ↑ https://doi.org/10.1111%2Fj.1440-1746.2006.04333.x
- ↑ https://books.google.com/books?id=PekixjgbRlcC&pg=PA240
- ↑ Jamshed, Namirah; Lee, Zone-En; Olden, Kevin W. (1 August 2011). "Diagnostic approach to chronic constipation in adults". American Family Physician. 84 (3): 299–306. ISSN 1532-0650. PMID 21842777
- ↑ http://www.emedicine.com/med/topic2833.htm
- ↑ Walia R, Mahajan L, Steffen R (October 2009). "Recent advances in chronic constipation". Curr Opin Pediatr. 21 (5): 661–6. doi:10.1097/MOP.0b013e32832ff241. PMID 19606041. S2CID
- ↑ Locke GR, Pemberton JH, Phillips SF (December 2000). "American Gastroenterological Association Medical Position Statement: guidelines on constipation". Gastroenterology. 119 (6): 1761–
- ↑ http://www.aafp.org/afp/2005/1201/p2277.html
- ↑ https://doi.org/10.1016%2Fj.dld.2013.03.016
- ↑ https://www.cdc.gov/cancer/ovarian/pdf/ovarian_facts.pdf
- ↑ https://en.wikipedia.org/wiki/World_Gastroenterology_Organisation
- ↑ https://www.niddk.nih.gov/health-information/urologic-diseases/bladder-control-problems-women/cystocele-prolapsed-bladder
- ↑ McCallum IJ, Ong S, Mercer-Jones M (2009). "Chronic constipation in adults". BMJ. 338: b831. doi:10.1136/bmj.b831. PMID
- ↑ https://doi.org/10.1016%2Fj.dld.2013.03.016
- ↑ https://doi.org/10.18773%2Faustprescr.2010.058
- ↑ Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM (January 2012). "Chronic constipation in the elderly". The American Journal of Gastroenterology (Review). 107 (1): 18–25. doi:10.1038/ajg.2011.349. PMID 21989145. S2CID 205099253
- ↑ Locke GR, Pemberton JH, Phillips SF (December 2000). "American Gastroenterological Association Medical Position Statement: guidelines on constipation". Gastroenterology. 119 (6): 1761–6. doi:10.1053/gast.2000.20390.
- ↑ Walia R, Mahajan L, Steffen R (October 2009). "Recent advances in chronic constipation". Curr Opin Pediatr. 21 (5): 661–6. doi:10.1097/MOP.0b013e32832ff241. PMID 19606041. S2CID 11606786.
- ↑ Gyger G, Baron M (2015).
- ↑ Rao, Satish S. C.; Rattanakovit, Kulthep; Patcharatrakul, Tanisa (2016). "Diagnosis and management of chronic constipation in adults". Nature Reviews Gastroenterology & Hepatology. 13 (5): 295–305. doi:10.1038/nrgastro.2016.53. PMID 27033126. S2CID 19608417.
- ↑ Schouten WR, Briel JW, Auwerda JJ, van Dam JH, Gosselink MJ, Ginai AZ, Hop WC (1997). "Anismus: fact or fiction?". Diseases of the Colon and Rectum. 40 (9): 1033–1041. doi:10.1007/BF02050925. PMID 9293931. S2CID 23587867.
- ↑ Pérez-Molina, José A.; Molina, Israel (6 January 2018). "Chagas disease". The Lancet. 391 (10115): 82–94. doi:10.1016/S0140-6736(17)31612-4. PMID 28673423. S2CID 4514617.
- ↑ Walia R, Mahajan L, Steffen R (October 2009). "Recent advances in chronic constipation". Curr Opin Pediatr. 21 (5): 661–6. doi:10.1097/MOP.0b013e32832ff241. PMID 19606041. S2CID 1160678
- ↑ 33.0 33.1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531555
- ↑ 34.0 34.1 Walia R, Mahajan L, Steffen R (October 2009). "Recent advances in chronic constipation". Curr Opin Pediatr. 21 (5): 661–6. doi:10.1097/MOP.0b013e32832ff241. PMID 19606041. S2CID 11606786
- ↑ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531555
- ↑ Wexner, Steven (2006). Constipation: etiology, evaluation and management. New York: Springer
- ↑ Tabbers, M.M.; DiLorenzo, C.; Berger, M.Y.; Faure, C.; Langendam, M.W.; Nurko, S.; Staiano, A.; Vandenplas, Y.; Benninga, M.A. (2014). "Evaluation and Treatment of Functional Constipation in Infants and Children". Journal of Pediatric Gastroenterology and Nutrition. 58 (2): 265–281. doi:10.1097/mpg.0000000000000266. PMID 24345831. S2CID 13834963